Paper405343
Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas.
Kessler E and 2 others. Invest Ophthalmol Vis Sci, 1977. Cited by 75 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas. Papers, record 405343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/405343
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen | Major topic |
| Cornea | Major topic |
| Peptide Hydrolases | Major topic |
| Proteoglycans | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Animals | |
| Corneal Ulcer | |
| Glucuronates | |
| Hexosamines | |
| Humans | |
| Hydroxyproline | |
| Methods | |
| Protease Inhibitors | |
| Rabbits |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,870,218 | A Bacterial Quorum Sensing Regulated Protease Inhibits Host Immune Responses by Cleaving Death Domains of Innate Immune Adaptors. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37870218 | PubMed |
| 34,097,906 | Foundational concepts in the biology of bacterial keratitis. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/34097906 | PubMed |
| 25,246,397 | A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25246397 | PubMed |
| 23,548,618 | Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23548618 | PubMed |
| 23,365,719 | Infectious keratitis: secreted bacterial proteins that mediate corneal damage. | J Ophthalmol | 2013 | https://conductscience.org/library/papers/23365719 | PubMed |
| 12,545,697 | The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis. | Trans Am Ophthalmol Soc | 2002 | https://conductscience.org/library/papers/12545697 | PubMed |
| 9,234,758 | Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections. | Infect Immun | 1997 | https://conductscience.org/library/papers/9234758 | PubMed |
| 8,224,956 | The role of Pseudomonas aeruginosa elastase in corneal ring abscess formation in pseudomonal keratitis. | Graefes Arch Clin Exp Ophthalmol | 1993 | https://conductscience.org/library/papers/8224956 | PubMed |
| 7,307,872 | The cornea in measles. | Doc Ophthalmol | 1981 | https://conductscience.org/library/papers/7307872 | PubMed |
| 7,263,073 | Age-related susceptibility of mice to ocular challenge with Pseudomonas aeruginosa exotoxin A. | Infect Immun | 1981 | https://conductscience.org/library/papers/7263073 | PubMed |
| 7,026,449 | Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease. | Infect Immun | 1981 | https://conductscience.org/library/papers/7026449 | PubMed |
| 6,815,099 | In vitro inhibition of Pseudomonas aeruginosa elastase by metal-chelating peptide derivatives. | Infect Immun | 1982 | https://conductscience.org/library/papers/6815099 | PubMed |
| 6,805,124 | Experimental Pseudomonas keratitis. | Trans Am Ophthalmol Soc | 1981 | https://conductscience.org/library/papers/6805124 | PubMed |
| 6,776,099 | Nutritional factors controlling exocellular protease production by Pseudomonas aeruginosa. | J Bacteriol | 1980 | https://conductscience.org/library/papers/6776099 | PubMed |
| 6,402,520 | Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. | J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6402520 | PubMed |
| 6,317,657 | Transposon mutagenesis of Pseudomonas aeruginosa exoprotease genes. | J Bacteriol | 1984 | https://conductscience.org/library/papers/6317657 | PubMed |
| 3,079,727 | Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase. | Infect Immun | 1986 | https://conductscience.org/library/papers/3079727 | PubMed |
| 2,127,341 | Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2127341 | PubMed |
| 2,110,137 | Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity. | J Bacteriol | 1990 | https://conductscience.org/library/papers/2110137 | PubMed |
| 1,903,770 | Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection. | Infect Immun | 1991 | https://conductscience.org/library/papers/1903770 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/405343
GET https://conductscience.org/api/papers/v1/405343/cited_by?page=2